Clinical phenotype and β-cell autoimmunity in Italian patients with adult-onset diabetes

Abstract

Objective: To characterize the phenotype of a large population of Italian patients with adult onset ($ 40 years) diabetes who were attending outpatient clinics and who were screened for glutamic acid decarboxylase 65 autoantibodies (GADA), protein tyrosine phosphatase IA-2 (IA-2A) and IA2b/phogrin (IA-2bA). Design and methods: This was a cross-sectional study comprising a total of 881 patients, aged # 70 years, diagnosed with type 2 diabetes after the age of 40 years, and consecutively recruited in five clinics located in different geographic areas of Italy (Milan, Florence, Rome, Naples and Catania). Their mean disease duration was 8.1 (6.9; S.D.) years. GADA, IA-2A and IA-2bA were measured with radiobinding assays with in vitro translated S-methionine-labelled glutamic acid decarboxylase 65 (GAD65) or IA-2 or IA-2b. Anthropometric and clinical data were collected and compared amongst patients with or without autoantibodies. Results: Sixty-three (7.1%) patients had one or more autoantibodies, 58 (6.6%) had GADA, 22 (2.5%) had IA-2A, six (0.7%) had IA-2bA and 19 (2.15%) had two or more autoantibodies. IA-2A or IA-2bA, in the absence of GADA, were found in only five patients. Autoantibody-positive patients were more often female (63.5 vs 36.5%; P , 0.009), had higher glycated haemoglobin (Hb A1c) (P , 0.001), lower body mass index (BMI; P , 0.0005) and waist/hip ratio (WHR; P , 0.01); female gender being the main contributor to BMI and WHR. We did not observe any differences in age at diagnosis or duration of disease with respect to the presence or absence of islet autoantibodies. The proportion of patients on insulin therapy was higher in patients with two or more antibodies, compared with those with one antibody only, and no antibodies (P for trend , 0.001), and among patients with GADA, in those with higher antibody titre (73.9% in those with . 10 units vs 42.0% in those with # 10 units; P , 0.007). Conclusions: Patients with adult onset diabetes characterized by autoimmunity to b-cells showed a clinical phenotype with anthropometric features that differed from those classically observed in patients with type 2 diabetes. The number and titre of autoantibodies, which reflect the severity of autoimmunity and b-cell impairment, amplified this difference. The usefulness of autoantibody screening in adult-onset diabetes is further emphasized by these findings. European Journal of Endocrinology 154 441-447

High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes

“…Compared with other large studies, this prevalence is less than those reported in some northern European populations such as in the U.K. Prospective Diabetes Study (6,7) and the Botnia Study (8), slightly lower than that of another Italian study (10), and very close to that of the international A Diabetes Outcome Progression Trial (9).…”

Clinical characteristics and autoantibody pattern in newly diagnosed adult‑onset autoimmune diabetes

“…7,33 diabetes in older age groups is characterized by an increase in the proportion of women is consistent with literature data. [26][27][28] However, there are still insufficient data to make a firm conclusion about the sex incidence of autoimmune diabetes over the age of 50 years. 25 Interestingly, we observed a correlation between the number of autoantibodies detected at diagnosis and sex distribution.…”

High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)

“…UKPDS 25 reported, in a larger population of LADA patients, that high GADA titer was associated with a significant higher risk of insulin requirement only among subjects older than 55 years at diagnosis (1). Afterwards, conflicting results were reported in the literature; some studies demonstrated that a high titer of GADA was associated with a shorter insulin-free period (9,10,11), whereas others did not support this hypothesis (6,12).…”